Solidifying ADCs as Early-Line Patient Therapies by De-Risking Differentiated Payload MoAs Beyond Topo1, Elevating ADCs to Deliver Wider Impact in the Clinical Landscape & Adapting Manufacturing Efficiency for Novel & Cost-Effective ADCs
With groundbreaking clinical impact of traditional ADCs in first-line metastatic indications and ambitions set on neoadjuvant settings, the new era of ADCs are starting to enter the clinic and attract dealmaking attention, unlocking the next wave of differentiated ADCs to redefine the future standard of care in oncology and beyond.
Returning as the largest and definitive ADC congress, the 17th World ADC San Diego is THE one-stop bioconjugate shop bringing together the global ADC community for an unparalleled amalgamation of case studies, development trends and networking opportunities to forge ADC innovation into differentiated, early-line patient outcomes.
With 7 streams of end-to-end ADC content across Discovery Chemistry, Discovery Biology, Preclinical, Translational Medicine, Clinical Lessons, Process & Analytical Development, and Manufacturing & Supply Stream, all the ADC innovation will be in the spotlight for an unmissable week of data and insights to de‑risk future ADC development and push ADCs into earlier‑line oncology treatments.
Uniting 1,300 industry senior enthusiasts from biopharma, innovative start-ups, leading service providers and academic, physician and regulator KOLs, World ADC San Diego is the place to be to discuss, debate and advance the future of ADC development.
Spotlighting Innovation: Sessions to Help Your ADC Stand Out
Cutting-Edge, End-to-End Scientific Content for All Stages of ADC Development
From new entrants to long-standing experts in the ADC field, 2026's 7-track program will delve into:
Snapshot of World Class ADC Speakers
Attending Companies Include
About the World ADC Event Series
The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value that World ADC provides you with is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.
We share a common belief with the industry – that the potential of antibody-drug conjugates is enormous. In the war against cancer, ADCs are shaping up to advance towards earlier line treatments, shaping the oncology standard of care and providing long-term benefit to patients.
Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs for patients faster.